Non Serious Adverse Drug Reactions Report

Start Date:2016-04-25 End Date:2016-04-26
Study :EMR700623-541Investigator :NACountry of Investigator :ChinaSiteNo:C02
Subject No :C02-0076Subject Initials :F-LDOB :05/15/1987Sex:FemaleRace:AsianHeight:150cmWeight:51.5kg
First administration date of batch :Batch number :
Study DrugStart DateDoseChange in Dose
Gonal-f New Pen Stimulation Treatment05/15/2015150
Adverse EventStart DateEnd DateTime related to study treatmentCausality to study drugSeverity
OHSS 05/27/201506/03/2015RelatedModerate
Causality FactorsAction Taken with Study TreatmentOther action takenOutcomeAE Special InterestAE dose limiting toxicity
None(Othervalue:)Not applicableLed to study terminationResolved
Event Description:Moderate OHSS patients, improved canceled after embryo transfer.
Subject received concomitant medications:
Does the subject have any relevant past or present medical conditions:Yes
ConditionStart DateRelated to study conditionOngoing
Sticky points lower pelvic laparoscopy surgery, tubal surgery.Uk-Unk-2012Not on treatment/medication
Hysteroscopic tubal surgeryUk-Sep-2014Not on treatment/medication



25-APR-16
NA/EMR700623-541/C02-0076
Page 1 of13
 

Non Serious Adverse Drug Reactions Report

Start Date:2016-04-25 End Date:2016-04-26
Study :EMR700623-541Investigator :NACountry of Investigator :ChinaSiteNo:C02
Subject No :C02-0082Subject Initials :Y-LDOB :09/04/1986Sex:FemaleRace:AsianHeight:162cmWeight:59.0kg
First administration date of batch :Batch number :
Study DrugStart DateDoseChange in Dose
Gonal-f New Pen Stimulation Treatment05/18/2015150
Adverse EventStart DateEnd DateTime related to study treatmentCausality to study drugSeverity
OHSS 05/30/201506/05/2015RelatedModerate
Causality FactorsAction Taken with Study TreatmentOther action takenOutcomeAE Special InterestAE dose limiting toxicity
None(Othervalue:)Not applicableLed to study terminationResolved
Event description:Moderate OHSS occurs canceled embryo transfer, OHSS improvement
Subject received concomitant medications:
Does the subject have any relevant past or present medical conditions:No
ConditionStart DateRelated to study conditionOngoing
 



25-APR-16
NA/EMR700623-541/C02-0082
Page 2 of 13
 

Non Serious Adverse Drug Reactions Report

Start Date:2016-04-25 End Date:2016-04-26
Study :EMR700623-541Investigator :NACountry of Investigator :ChinaSiteNo:C02
Subject No :C02-0083Subject Initials :Y-LDOB :08/20/1988Sex:FemaleRace:AsianHeight:158cmWeight:54.0kg
First administration date of batch :Batch number :
Study DrugStart DateDoseChange in Dose
Gonal-f New Pen Stimulation Treatment05/18/2015150
Adverse EventStart DateEnd DateTime related to study treatmentCausality to study drugSeverity
OHSS 05/31/201506/05/2015RelatedModerate
Causality FactorsAction Taken with Study TreatmentOther action takenOutcomeAE Special InterestAE dose limiting toxicity
None(Othervalue:)Not applicableLed to study terminationResolved
Event description:Moderate OHSS patients, improved canceled after embryo transfer.
Subject received concomitant medications:
Does the subject have any relevant past or present medical conditions:Yes
ConditionStart DateRelated to study conditionOngoing
Laparoscopic pelvic sticky points left salpingostomyUk-Unk-2013Not on treatment/medication
 



25-APR-16
NA/EMR700623-541/C02-0083
Page 3 of 13
 

Non Serious Adverse Drug Reactions Report

Start Date:2016-04-25 End Date:2016-04-26
Study :EMR700623-541Investigator :NACountry of Investigator :ChinaSiteNo:C02
Subject No :C02-0086Subject Initials :YZZDOB :07/07/1987Sex:FemaleRace:AsianHeight:150cmWeight:55.0kg
First administration date of batch :Batch number :
Study DrugStart DateDoseChange in Dose
Gonal-f New Pen Stimulation Treatment05/18/2015150
Adverse EventStart DateEnd DateTime related to study treatmentCausality to study drugSeverity
OHSS 06/01/201506/12/2015RelatedModerate
Causality FactorsAction Taken with Study TreatmentOther action takenOutcomeAE Special InterestAE dose limiting toxicity
None(Othervalue:)Not applicableLed to study terminationResolved
Event description:Moderate OHSS occurs canceled embryo transfer, OHSS improvement
Subject received concomitant medications:
Does the subject have any relevant past or present medical conditions:No
ConditionStart DateRelated to study conditionOngoing
 



25-APR-16
NA/EMR700623-541/C02-0086
Page 4 of 13
 

Non Serious Adverse Drug Reactions Report

Start Date:2016-04-25 End Date:2016-04-26
Study :EMR700623-541Investigator :NACountry of Investigator :ChinaSiteNo:C02
Subject No :C02-0087Subject Initials :XPTDOB :06/15/1988Sex:FemaleRace:AsianHeight:158cmWeight:57.0kg
First administration date of batch :Batch number :
Study DrugStart DateDoseChange in Dose
Gonal-f New Pen Stimulation Treatment
Adverse EventStart DateEnd DateTime related to study treatmentCausality to study drugSeverity
OHSS 05/30/201506/05/2015RelatedModerate
Causality FactorsAction Taken with Study TreatmentOther action takenOutcomeAE Special InterestAE dose limiting toxicity
None(Othervalue:)Not applicableLed to study terminationResolved
Event description:Moderate OHSS patients, improved canceled after embryo transfer.
Subject received concomitant medications:
Does the subject have any relevant past or present medical conditions:Yes
ConditionStart DateRelated to study conditionOngoing
Hysteroscopy normalUk-Mar-2015Not on treatment/medication
 



25-APR-16
NA/EMR700623-541/C02-0087
Page 5 of 13
 

Non Serious Adverse Drug Reactions Report

Start Date:2016-04-25 End Date:2016-04-26
Study :EMR700623-541Investigator :NACountry of Investigator :ChinaSiteNo:C02
Subject No :C02-0088Subject Initials :HLKDOB :06/14/1986Sex:FemaleRace:AsianHeight:159cmWeight:59.0kg
First administration date of batch :Batch number :
Study DrugStart DateDoseChange in Dose
Gonal-f New Pen Stimulation Treatment05/18/2015150
Adverse EventStart DateEnd DateTime related to study treatmentCausality to study drugSeverity
OHSS 05/30/201506/05/2015RelatedModerate
Causality FactorsAction Taken with Study TreatmentOther action takenOutcomeAE Special InterestAE dose limiting toxicity
None(Othervalue:)Not applicableLed to study terminationResolved
Event description:Moderate OHSS occurs canceled embryo transfer, OHSS improvement
Subject received concomitant medications:
Does the subject have any relevant past or present medical conditions:Yes
ConditionStart DateRelated to study conditionOngoing
Palace laparoscopic pelvic surgery sticky points, bilateral tubal plastic surgery, endometriosis lesions fulguration.Uk-Unk-2012Not on treatment/medication
 



25-APR-16
NA/EMR700623-541/C02-0088
Page 6 of 13
 

Non Serious Adverse Drug Reactions Report

Start Date:2016-04-25 End Date:2016-04-26
Study :EMR700623-541Investigator :NACountry of Investigator :ChinaSiteNo:C02
Subject No :C02-0089Subject Initials :XYZDOB :06/12/1986Sex:FemaleRace:AsianHeight:152cmWeight:48.5kg
First administration date of batch :Batch number :
Study DrugStart DateDoseChange in Dose
Gonal-f New Pen Stimulation Treatment05/18/2015187.5
Adverse EventStart DateEnd DateTime related to study treatmentCausality to study drugSeverity
OHSS 06/04/201506/12/2015RelatedModerate
Causality FactorsAction Taken with Study TreatmentOther action takenOutcomeAE Special InterestAE dose limiting toxicity
None(Othervalue:)Not applicableLed to study terminationResolved
Event description:Moderate OHSS patients, improved canceled after embryo transfer.
Subject received concomitant medications:
Does the subject have any relevant past or present medical conditions:Yes
ConditionStart DateRelated to study conditionOngoing
Sticky points pelvic laparoscopy surgery, tubal surgery to clearUk-Nov-2012Not on treatment/medication
 



25-APR-16
NA/EMR700623-541/C02-0089
Page 7 of 13
 

Non Serious Adverse Drug Reactions Report

Start Date:2016-04-25 End Date:2016-04-26
Study :EMR700623-541Investigator :NACountry of Investigator :ChinaSiteNo:C02
Subject No :C02-0095Subject Initials :MLGDOB :08/19/1990Sex:FemaleRace:AsianHeight:155cmWeight:54.0kg
First administration date of batch :Batch number :
Study DrugStart DateDoseChange in Dose
Gonal-f New Pen Stimulation Treatment05/19/2015150
Adverse EventStart DateEnd DateTime related to study treatmentCausality to study drugSeverity
OHSS 05/31/201506/05/2015RelatedModerate
Causality FactorsAction Taken with Study TreatmentOther action takenOutcomeAE Special InterestAE dose limiting toxicity
None(Othervalue:)Not applicableLed to study terminationResolved
Event description:Moderate OHSS occurs canceled embryo transfer, OHSS improvement
Subject received concomitant medications:
Does the subject have any relevant past or present medical conditions:No
ConditionStart DateRelated to study conditionOngoing
 



26-APR-16
NA/EMR700623-541/C02-0095
Page 8 of 13
 

Non Serious Adverse Drug Reactions Report

Start Date:2016-04-25 End Date:2016-04-26
Study :EMR700623-541Investigator :NACountry of Investigator :ChinaSiteNo:C02
Subject No :C02-0102Subject Initials :HYDDOB :10/14/1985Sex:FemaleRace:AsianHeight:163cmWeight:57.0kg
First administration date of batch :Batch number :
Study DrugStart DateDoseChange in Dose
Gonal-f New Pen Stimulation Treatment05/19/2015150
Adverse EventStart DateEnd DateTime related to study treatmentCausality to study drugSeverity
OHSS 06/01/201506/12/2015RelatedModerate
Causality FactorsAction Taken with Study TreatmentOther action takenOutcomeAE Special InterestAE dose limiting toxicity
None(Othervalue:)Not applicableLed to study terminationResolved
Event Description:Moderate OHSS patients, improved canceled after embryo transfer.
Subject received concomitant medications:
Does the subject have any relevant past or present medical conditions:Yes
ConditionStart DateRelated to study conditionOngoing
Palace laparoscopy Uk-Unk-2013Not on treatment/medication



26-APR-16
NA/EMR700623-541/C02-0102
Page 9 of13